SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0000769993-17-000307
Filing Date
2017-02-10
Accepted
2017-02-10 12:16:22
Documents
1
Group Members
GOLDMAN, SACHS & CO.

Document Format Files

Seq Description Document Type Size
1 CLOVIS ONCOLOGY 13G AMENDMENT 1 clovisoncologyinc1gscototal.txt SC 13G/A 21927
  Complete submission text file 0000769993-17-000307.txt   23622
Mailing Address 200 WEST STREET NEW YORK NY 10282
Business Address 200 WEST STREET NEW YORK NY 10282 2129021000
GOLDMAN SACHS GROUP INC (Filed by) CIK: 0000886982 (see all company filings)

IRS No.: 134019460 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A
SIC: 6211 Security Brokers, Dealers & Flotation Companies

Mailing Address 5500 FLATIRON PARKWAY SUITE 100 BOULDER CO 80301
Business Address 5500 FLATIRON PARKWAY SUITE 100 BOULDER CO 80301 (303) 625-5000
Clovis Oncology, Inc. (Subject) CIK: 0001466301 (see all company filings)

IRS No.: 900475355 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-86488 | Film No.: 17591290
SIC: 2834 Pharmaceutical Preparations